Wexford Science & Technology
Wexford Science & Technology, LLC specializes in real estate strategies and solutions tailored for universities, academic medical centers, and research institutions. The company collaborates closely with its partner institutions to design and develop dynamic, mixed-use communities that promote research, discovery, and entrepreneurship. Wexford's services encompass construction, development planning, marketing, leasing, asset management, and financial investment for various real estate projects, all aimed at fostering vibrant environments conducive to innovation and collaboration.
3Daughters
Seed Round in 2024
3Daughters is a women's healthcare company focused on developing an innovative intrauterine device (IUD) designed to improve the experience of contraception for female patients. Their nonhormonal, frameless device utilizes three small elliptical magnetic units, representing a significant advancement over traditional T-shaped IUDs, which often cause discomfort, perforation, and expulsion during insertion. By addressing these common issues associated with existing devices, 3Daughters aims to provide women with enhanced contraceptive options that prioritize comfort and efficacy.
3Daughters
Seed Round in 2024
3Daughters is a women's healthcare company focused on developing an innovative intrauterine device (IUD) designed to improve the experience of contraception for female patients. Their nonhormonal, frameless device utilizes three small elliptical magnetic units, representing a significant advancement over traditional T-shaped IUDs, which often cause discomfort, perforation, and expulsion during insertion. By addressing these common issues associated with existing devices, 3Daughters aims to provide women with enhanced contraceptive options that prioritize comfort and efficacy.
Previse
Seed Round in 2023
Capsulomics, LLC is a biotechnology company focused on developing and manufacturing DNA tests for the early detection of upper gastrointestinal (GI) cancers, particularly esophageal cancer and its precancerous condition, Barrett’s esophagus. Founded in 2018 and based in Halethorpe, Maryland, Capsulomics aims to address the diagnostic and prognostic uncertainties associated with GI diseases. By providing advanced diagnostic solutions, the company enables healthcare professionals to prevent, detect, and treat these conditions more effectively, ultimately enhancing patient outcomes.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at
support@teaserclub.com. Your feedback is most welcome.